Breastfeeding factors and risk of epithelial ovarian cancer.


Journal

Gynecologic oncology
ISSN: 1095-6859
Titre abrégé: Gynecol Oncol
Pays: United States
ID NLM: 0365304

Informations de publication

Date de publication:
04 2019
Historique:
received: 11 12 2018
revised: 17 01 2019
accepted: 20 01 2019
pubmed: 29 1 2019
medline: 14 5 2019
entrez: 29 1 2019
Statut: ppublish

Résumé

Previous studies suggest that breastfeeding reduces epithelial ovarian cancer (EOC) risk. However, the effects of age, timing and episode details on the EOC-breastfeeding relationship have not been examined. The objective of this study was to examine the association between breastfeeding factors and epithelial ovarian cancer. We examined breastfeeding factors among parous women in a population-based, case-control study conducted in Pennsylvania, Ohio, and New York from 2003 to 2008. We compared 689 incident EOC cases to 1572 community controls. Multivariable unconditional logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) associated with breastfeeding patterns adjusting for potential confounders. Compared to never breastfeeding, breastfeeding any offspring was associated with a 30% reduction in EOC risk (OR = 0.70; 95%CI = 0.58-0.85). That association lasted more than 30 years (OR = 0.69, 95%CI = 0.53-0.88). An average breastfeeding episode of 3 months was also associated with reduced risk (OR = 0.73, 95%CI = 0.58-0.80). A greater number of breastfeeding episodes was associated with greater risk reduction (OR = 0.78, 95%CI = 0.64-0.96 and OR = 0.49, 95%CI = 0.36-0.68 1-2 and 3+ episodes, respectively, compared to never breastfed, trend p = 0.01). Longer breastfeeding duration was also associated with reduced risk (OR = 0.75 and 0.62 for less than and greater than 1-year total duration, respectively, compared to never breastfed). An earlier age at first breastfeeding was further associated with increased protection (OR = 0.50-0.80, for first episode at age <25, 25-29, and 30+, respectively, trend p = 0.001). Breastfeeding for as few as 3 months is associated with reduced EOC risk. Although this association decreases over time, it persists for more than 30 years. Longer cumulative duration, increasing number of breastfeeding episodes, and earlier age at first breastfeeding episode are each associated with increased benefit.

Identifiants

pubmed: 30686553
pii: S0090-8258(19)30060-5
doi: 10.1016/j.ygyno.2019.01.017
pmc: PMC6558958
mid: NIHMS1026520
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

116-122

Subventions

Organisme : NCI NIH HHS
ID : K07 CA080668
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA095023
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA188900
Pays : United States

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Références

Ann Epidemiol. 2001 Nov;11(8):568-74
pubmed: 11709277
Reprod Fertil Dev. 2001;13(7-8):583-90
pubmed: 11999309
Sociol Methodol. 1988;18:37-68
pubmed: 12282712
Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):42-6
pubmed: 12540502
Lancet. 1991 Mar 23;337(8743):715-7
pubmed: 1672186
Curr Opin Obstet Gynecol. 2007 Feb;19(1):3-9
pubmed: 17218844
Pediatrics. 1992 Mar;89(3):437-40
pubmed: 1741218
Cancer Causes Control. 2007 Jun;18(5):517-23
pubmed: 17450440
Lancet. 2008 Jan 26;371(9609):303-14
pubmed: 18294997
Am J Epidemiol. 2008 May 1;167(9):1059-69
pubmed: 18303003
Annu Rev Pathol. 2009;4:287-313
pubmed: 18842102
Am J Perinatol. 2009 Jan;26(1):81-8
pubmed: 19031350
Cancer Causes Control. 2010 Jan;21(1):109-16
pubmed: 19779839
Cancer Causes Control. 2010 Feb;21(2):201-7
pubmed: 19902367
Epidemiology. 2012 Mar;23(2):311-9
pubmed: 22252409
Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3921-6
pubmed: 22331912
Pediatrics. 2012 Mar;129(3):e827-41
pubmed: 22371471
Natl Health Stat Report. 2012 Apr 12;(51):1-28
pubmed: 22803225
Ann Intern Med. 2012 Dec 18;157(12):900-4
pubmed: 22964825
Clin Cancer Res. 2012 Nov 15;18(22):6199-207
pubmed: 22967960
Int J Gynecol Cancer. 2012 Oct;22(8):S45-57
pubmed: 23013733
Endocr Relat Cancer. 2012 Nov 09;19(6):R255-79
pubmed: 23045324
Obstet Gynecol. 2013 Jul;122(1):139-47
pubmed: 23743450
Am J Clin Nutr. 2013 Oct;98(4):1020-31
pubmed: 23966430
Gynecol Oncol. 2014 Feb;132(2):322-7
pubmed: 24355484
Asian Pac J Cancer Prev. 2014;15(12):4829-37
pubmed: 24998548
Asian Pac J Cancer Prev. 2015;16(12):4987-91
pubmed: 26163627
Obstet Gynecol. 2016 Feb;127(2):e86-92
pubmed: 26942393
Am J Cancer Res. 2016 Oct 01;6(10):2334-2344
pubmed: 27822422
J Prev Med Public Health. 2016 Nov;49(6):349-366
pubmed: 27951628
Lancet. 1971 Jul 17;2(7716):163
pubmed: 4104488
J Natl Cancer Inst. 1983 Oct;71(4):717-21
pubmed: 6578367
Lancet. 1994 Nov 5;344(8932):1250-4
pubmed: 7967985
Int J Epidemiol. 1993 Apr;22(2):192-7
pubmed: 8505173

Auteurs

Francesmary Modugno (F)

Womens Cancer Research Program, Magee-Womens Research Institute and UPMC Hillman Cancer Center, USA; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Electronic address: modugnof@upmc.edu.

Sharon L Goughnour (SL)

Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Electronic address: goughnours@mwri.magee.edu.

Danielle Wallack (D)

Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA.

Robert P Edwards (RP)

Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Electronic address: edwarp@mail.magee.edu.

Kunle Odunsi (K)

Roswell Park Cancer Institute, Buffalo, NY, USA. Electronic address: Kunle.Odunsi@roswellpark.org.

Joseph L Kelley (JL)

Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Electronic address: kelljl2@mail.magee.edu.

Kirsten Moysich (K)

Roswell Park Cancer Institute, Buffalo, NY, USA. Electronic address: Moysich@roswellpark.org.

Roberta B Ness (RB)

University of Texas School of Public Health, Houston, TX, USA. Electronic address: Roberta.B.Ness@uth.tmc.edu.

Maria Mori Brooks (MM)

Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA. Electronic address: brooks@edc.pitt.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH